Michael A. Greeley

Michael is a General Partner at Flybridge Capital Partners focused on information technology, healthcare and medical technology investments. Among a range of general investment themes, Michael is currently focused on opportunities involving, the convergence of healthcare and IT, technology-enabled business services, and technologies that address the physical security and homeland defense markets.

Michael currently represents the firm on the boards of BlueTarp, MicroCHIPS, Predictive Biosciences, Protein Forest and VidSys and led the firm's investment in T2 Biosystems and Magen BioSciences.

Michael founded IDG Ventures Atlantic in 2001 before it transitioned to Flybridge Capital Partners in 2008. Michael continues to serve on the board of International Data Group, the flagship Limited Partner for the IDG Ventures global network of funds.

Previously, Michael was with Polaris Venture Partners, where he focused on both early-stage and later-stage financings for emerging growth companies. Before Polaris, Michael served as Senior Vice President and Founding Partner of GCC Investments, a $200 million private equity fund. Prior to GCC Investments, Michael was a Vice President and one of the early professionals at Wasserstein Perella & Co., an international merchant bank with a $1.0 billion private equity fund. Additionally, Michael was a member of the Mergers and Acquisitions Department of Morgan Stanley & Co. and worked in the Leveraged Buyout Group of Credit Suisse First Boston.

Michael currently serves as the President of the New England Venture Capital Association and serves on the investment committee of the Partners Healthcare Fund. He is also a member of the Executive Business Advisory Council for Mass General Hospital for Children, and a trustee and on the investment committee of the Massachusetts Eye and Ear Infirmary. In addition to blogging for Xconomy, Michael authors a column called "Nothing Ventured" for BioIT World magazine.

Michael received a BA with honors in Chemistry from Williams College and an MBA from Harvard Business School.